Health TrialsbyHealthPanel

A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

ConditionAcne
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorEquipmed USA LLC

About this trial

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female subjects aged between 18-45 years (both ages inclusive)

Fitzpatrick skin phototype I to VI.

Subjects having IGA score of 2 and 3.

Subjects who have not received any kind of treatment for acne 1 month before the start of the study.

Disqualifiers

Subjects with known skin condition that may impact the assessment.

Subjects with active Herpes labialis infection.

Subjects known to have bleeding and clotting disorders (self-declared).

Subjects known to have connective tissue disorders.

Trial design

Design model

Single group

Treatments tested in this trial

  • Dermapen 4™

    Combination product

    Dermapen 4™ conjunction with MG-CLR

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: A single arm, full face clinical study.Other 1 intervention

Trial outcomes

Primary outcomes

1

Acne severity

Change in acne severity using the modified GAGS scale at all time points when compared to baseline.

Time frame
13 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Equipmed USA LLC

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: